Las Vegas, NV -- (SBWIRE) -- 12/24/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more. EquityObserver.com issues a special report on the following stocks: Plug Power Inc(NASDAQ:PLUG),Rexahn Pharmaceuticals, Inc.(NYSEMKT:RNN),New Gold Inc.(TSE:NGD),Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN)
Plug Power Inc(NASDAQ:PLUG)managed to keep its loss at -3.80% on below-normal volume of 2.97Mshares. The stock settled at $1.77, after floating in a range of $1.76 - 1.86. Its latest price has reached market capitalization of $180.36M. Its 52-week range has been $0.12 - 2.24. Plug Power Inc. (Plug Power), is a provider of alternative energy technology focused on the design, development, commercialization and manufacture of fuel cell systems for the industrial off-road (forklift or material handling) market.
How Should Investors Trade PLUG Now?Don’t Miss out a Special Trend Analysis
Rexahn Pharmaceuticals, Inc.(NYSEMKT:RNN)trading on a volume of 2.72Mshares, higher than its standard daily volume. Shares have been closed at $0.475. Over the last twelve months, the stock has gained62.34% and faced a worst price of $0.28.Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide.
Is RNN a Solid Investment at These Levels?Read This Report for Details
New Gold Inc.(TSE:NGD)is down at $5.09 on below- normal volume of 624,850.00shares during the last trading day. The stock has its 12-month range $4.99 - 11.28. Its Intraday range is $5.07 - 5.23.New Gold Inc. is engaged in gold mining and related activities, including acquisition, exploration, extraction, processing and reclamation.
How Should Investors Trade NGD Now?Don’t Miss out a Special Trend Analysis
In the last trading day, Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN)is on high volume, trading at a volume of versus its average daily volume ratio 3.66M/2.31Mshares. At $3.46, the stock has attained market capitalization of 334.38M.Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases.
Will Investors Buy ACHN After Reading This News?Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)